TSX Gold and Mining Stocks News Alert: LOMIKO (TSXV:LMR) TO EXPLORE MAGNETIC ANOMALIES AT VINES LAKE GOLD PROJECT
Mar. 10, 2011
Vancouver, (InvestorIdeas Mining Stocks Newswire) LOMIKO METALS INC. (TSXV:LMR) (OTC:LMRMF) (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,)("Lomiko" or "the Company) Lomiko Metals Inc. holds the rights to three contiguous mineral tenures, totaling 1,169 Ha (2,888 Acres) located in the southwestern corner of the Cassiar Gold District or ‘Cassiar Gold Camp'.
Due to the property's close proximity to formerly producing mines with a proven history in the Cassiar Mining Camp, it is the opinion of the company that potential exists on the 100% owned Vines Lake Property for discovering new high-grade gold vein systems. Also, there is a potential for other intrusion related mineralization proximity along with the presence of the Cassiar Batholith and its associated boundary contacts, over which Lomiko's Vines Lake property claims are located.
In the latest technical report on the Vines Lake Project dated April 30, 2009, Garth Kirkham, P.Geo and Qualified Person for the Project recommends an exploration program for the Vines Lake Project. This program is designed to target both potentially high-grade gold vein systems, as seen at the adjacent Table Mountain Mine, in addition to the prospect of intrusion related mineralization. Phase I of the program is targeted to begin as soon as weather and snow conditions permit. Phase II will explore follow-up targets resulting from the geological mapping, geochemical and ground geophysical surveys resulting from Phase I.
Mr. Garth Kirkham, P.Geo is a Director of Lomiko Metals Inc. in addition to being the Qualified Person for the Vines Lake Project and has reviewed the technical data in this news release.
For more information, please contact Paul Gill at 604-729-5312, email: info@lomiko.com or refer to the website at: www.lomiko.com
On behalf of Lomiko Metals Inc,
Signed: "A. Paul Gill"
A. Paul Gill, President & CEO
We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Lomiko:
Lomiko Metals Inc. is a Canadian-based junior company whose objective is to increase shareholder value through the acquisition and exploration of high quality mineral mining projects and development into a fully integrated battery supplier. Lomiko is currently exploring for salt brines that contain lithium, sodium, sulfate, chloride and potash in salt lakes or salars. Lomiko's growth strategy is to become a fully integrated supplier of lithium ion batteries. The potential for partnership in creating lithium rechargeable batteries to replace current polluting methods of energy is excellent. Interest in lithium and lithium batteries is growing exponentially. The Company is committed to its development program and in showing corporate social and environmental stewardship in the arena.
Disclaimer/disclosure: The following Lomiko Metals news release is paid for by third party on behalf of LMR.V (five hundred for 1day of service). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
cvanzant@investorideas.com
Source - Investorideas.com, Lomiko Metals
Thursday, March 10, 2011
Q&A interview with Illinois based musician, Dan Ross; Walking for Peace and the People of Pine Ridge Reservation April 15th
Investorideas.com presents a recent Q&A interview with Illinois based musician, Dan Ross, as he gets ready for his 2000 mile walk across America for peace and the people of Pine Ridge Reservation in April.
On April 15, Dan Ross begins his walk from Chicago, Illinois to the Oregon coast.
Funds raised from his walk will be donated to the youth of the Pine Ridge Reservation and the non-profit ONE Spirit.
Investorideas.com tells readers what motivates a musician known as "Goofy Guitarist" on YouTube.com to walk for the people of Pine Ridge.
Pine Ridge is an Oglala Sioux Native American reservation located in South Dakota. Pine Ridge is the eighth-largest reservation in the UnitedStates
, and is also sadly, the poorest
Q: Investorideas.com
Dan, you walk for peace is in Synchrodestiny with the universe now as we have witnessed one of the most dramatic and peaceful protests by a people in Egypt.
Can you tell us what motivated and inspired you to take on such a challenging endeavor?
A: Dan Ross
Q: Investorideas.com
You have chose the youth of the Pine Ridge Reservation and the building of the Safe House and youth center as your non-profit to dedicate this to. A white youth from Illinois dedicating his walk to the native youth at Pine Ridge is an unexpected storyline; can you tell us how that came to be?
A: Dan Ross
Q: Investorideas.com
Listening to your music, and you are really good by the way, one of your songs is called "Taking action ". Is that how you live your life?
A: Dan Ross
Q: Investorideas.com
We saw with Egypt how the young protesters made effective use of Facebook.com and Twitter.com to get their message and story out. Do you see it playing a big role in your walk and getting donations and awareness?
A: Dan Ross
Q: Investorideas.com
What is your goal in terms of dollar amount you hope to raise with your walk and how can people donate and support what you are doing?
A: Dan Ross
Q: Investorideas.com
Any inspirational words for our readers in closing?
A: Dan Ross
Follow Dan On Facebook
Learn more about Dan's mission at his facebook group:
Dan Ross Walks to the Pacific
Hear Dan's:
http://www.youtube.com/user/goofyguitarist11
ONE Spirit is proud to be able to offer a way for you to directly help a Lakota child, family, or elder in need.
http://www.nativeprogress.org/
ONE Spirit is a Native American service organization founded to assist and support American Indians. We are proud to think of our organization, ONE Spirit, as a group of people who exchange friendship, with American Indians. at present our focus is the Lakota Sioux in South Dakota. We invite you to become part of ONE Spirit's network of sponsors, partners, friends and volunteers, to dream with the Lakota people a new dream - and to help the dreams come alive!
Mission
The ONE Spirit Mission is to assist the Lakota people in preserving and revitalizing the Lakota culture, language, and self-sufficiency while meeting the basic needs of Lakota families, children, and elders. We strive to cultivate an intercultural relationship that recognizes that we are all related and that American Indians are an equal and valued part of our society.
Follow One Spirit on Twitter
Follow One Spirit's Blog
Jeri Baker
ONE Spirit Executive Director
570-460-6567
jbaker@nativeprogress.org
Diane Capalario
ONE Spirit Assistant Director
dcapalario@nativeprogress.org
About Investorideas.com
Investor ideas that can change the world
Learn more about the non - profits we support and endorse
http://www.investorideas.com/About/Newsletter/CharitableCauses.asp
Contact Investorideas.com 800 665 0411
Dvanzant@investorideas.com
Investorideas.com presents a recent Q&A interview with Illinois based musician, Dan Ross, as he gets ready for his 2000 mile walk across America for peace and the people of Pine Ridge Reservation in April.
On April 15, Dan Ross begins his walk from Chicago, Illinois to the Oregon coast.
Funds raised from his walk will be donated to the youth of the Pine Ridge Reservation and the non-profit ONE Spirit.
Investorideas.com tells readers what motivates a musician known as "Goofy Guitarist" on YouTube.com to walk for the people of Pine Ridge.
Pine Ridge is an Oglala Sioux Native American reservation located in South Dakota. Pine Ridge is the eighth-largest reservation in the United
Q: Investorideas.com
Dan, you walk for peace is in Synchrodestiny with the universe now as we have witnessed one of the most dramatic and peaceful protests by a people in Egypt.
Can you tell us what motivated and inspired you to take on such a challenging endeavor?
A: Dan Ross
Q: Investorideas.com
You have chose the youth of the Pine Ridge Reservation and the building of the Safe House and youth center as your non-profit to dedicate this to. A white youth from Illinois dedicating his walk to the native youth at Pine Ridge is an unexpected storyline; can you tell us how that came to be?
A: Dan Ross
Q: Investorideas.com
Listening to your music, and you are really good by the way, one of your songs is called "Taking action ". Is that how you live your life?
A: Dan Ross
Q: Investorideas.com
We saw with Egypt how the young protesters made effective use of Facebook.com and Twitter.com to get their message and story out. Do you see it playing a big role in your walk and getting donations and awareness?
A: Dan Ross
Q: Investorideas.com
What is your goal in terms of dollar amount you hope to raise with your walk and how can people donate and support what you are doing?
A: Dan Ross
Q: Investorideas.com
Any inspirational words for our readers in closing?
A: Dan Ross
Follow Dan On Facebook
Learn more about Dan's mission at his facebook group:
Dan Ross Walks to the Pacific
Hear Dan's:
http://www.youtube.com/user/goofyguitarist11
ONE Spirit is proud to be able to offer a way for you to directly help a Lakota child, family, or elder in need.
http://www.nativeprogress.org/
ONE Spirit is a Native American service organization founded to assist and support American Indians. We are proud to think of our organization, ONE Spirit, as a group of people who exchange friendship, with American Indians. at present our focus is the Lakota Sioux in South Dakota. We invite you to become part of ONE Spirit's network of sponsors, partners, friends and volunteers, to dream with the Lakota people a new dream - and to help the dreams come alive!
Mission
The ONE Spirit Mission is to assist the Lakota people in preserving and revitalizing the Lakota culture, language, and self-sufficiency while meeting the basic needs of Lakota families, children, and elders. We strive to cultivate an intercultural relationship that recognizes that we are all related and that American Indians are an equal and valued part of our society.
Follow One Spirit on Twitter
Follow One Spirit's Blog
Jeri Baker
ONE Spirit Executive Director
570-460-6567
jbaker@nativeprogress.org
Diane Capalario
ONE Spirit Assistant Director
dcapalario@nativeprogress.org
About Investorideas.com
Investor ideas that can change the world
Learn more about the non - profits we support and endorse
http://www.investorideas.com/About/Newsletter/CharitableCauses.asp
Contact Investorideas.com 800 665 0411
Dvanzant@investorideas.com
Wednesday, March 09, 2011
Q&A; Josh Levine from MicroCap Investor Newsletter Shares Cleantech Investment Outlook and Strategy
New York, NY, Point Roberts WA, March 9, 2011 – Investorideas.com, a leader in cleantech stock research releases a recent Q&A with Josh Levine of the MicroCap Investor newsletter, discussing his cleantech investment outlook and strategy.
Investorideas.com Cleantech Interview:
Q: Investorideas.com
Josh, with oil prices surging above $100, cleantech is getting a lot more attention again from Wall Street and independent investors. I know you look at the long term investment picture, so what do you think is driving cleantech and what is your outlook for opportunities in this sector?
A: Josh Levine, MicroCap Investor http://www.levinesmicrocapinvestor.com/
Let's first qualify what is meant by the term cleantech. Cleantech is often used interchangeably with green technologies and alternative energy, but it seems to be the one that's emerged to encompass all these things. Cleantech essentially covers technologies that are more energy-efficient than conventional technologies and offer more environmentally-friendly alternatives to fossil-fuel-driven energy applications.
Broadly speaking, the world is always moving towards more efficient use of resources. Year after year and decade after decade, we manage to get more out of a given amount of resources. The first industrial revolution was powered by coal and though it provided tremendous gains in production, the pollution negatively impacted the quality of life and health of millions of people.
In the past century, while coal continued to have a prominent role, oil reigned as the fuel of choice because its energy density is so high, it was incredibly abundant, and it's easy to transport. The downside is that the oil supply is finite and that the burning of it leaves an undesirable byproduct. Today, it's becoming increasingly more costly to find and produce new oil -- and that's critical in the energy equation.
This brings us to cleantech opportunities, which are only just emerging after very long periods of incubation in research and development. What's happening today is a huge shift in the consciousness of governments, corporations and consumers. Of course lots of people are talking about energy efficiency, but there are also many now taking action on all levels.
Several things are driving this shift toward cleantech including climate change, the fear of running out of global oil supplies, rising world population and the limits of natural resources, higher energy costs, and environmental concerns. And then there's the surging demand from China. That's a pretty powerful mix. And when we combine these forces with the progress being made in new energy technologies, investors have a remarkable opportunity for profits.
The first electric cars are hitting the road this year after several years of hybrids, and the prospects for broad adoption over the next several years are very promising. With this comes the need for infrastructure to support car charging and that will spawn huge investments in the electric grid and networks to support these new vehicles around the U.S. and all over the world.
Of course solar and wind will continue to grow as their costs approach parity with conventional energy and they address important niches in the energy sphere. Additionally, there are so many other technologies that are part of the cleantech ecosystem and critical to the development of these markets, including batteries, fuel cells, inverters, demand response and energy management systems, ultracapacitors, superconductor cables and so much more.
To succeed in cleantech, investors really need to stay focused on the bigger picture and to be patient. The energy space moves far slower than, for example, the IT world, so developments unfold at a different rate. But once these technologies start gaining market traction, the valuations of the leading small innovative cleantech companies will generate fantastic returns for investors who got an early start.
Q: Investorideas.com
You recently just added a new cleantech stock to your portfolio. Can you give us some insight as to what qualified this particular stock based on your investing model?
A: Josh Levine, MicroCap Investor
My latest recommendation in unusual company which has developed and commercialized environmentally safe alternatives to plastics used for food containers, utensils, product wraps, as well as a wide range of parts in autos and many other things. Importantly, it meets all of my most important criteria for a great microcap investment.
As a cleantech play, this company's biodegradeable and completely safe products can replace petroleum-based polypropylene packaging. The result is less use of oil and a better outcome for the environment. It's a strong proposition.
It's a classic microcap story with all of the fundamentals in place for soaring growth -- a unique technology platform that's been validated by major customers worldwide, an experienced and proven management team, and powerful market drivers bolstered by increasing demand.
This company is addressing markets representing annual sales in the tens of billions of dollars, it has proven technology and products that are being rapidly adopted by large corporate customers, it has manufacturing capacity to scale several times current production, and its products are already on parity with polypropylene now that oil prices are north of $100.
In 2010, sales revenue for this company was $6.3 million, a 133% increase versus 2009, and projected revenue for the 2011 full year is between $24 million and $32 million -- a whopping 300% to 400% increase over 2010!
With all this going for it, this company is still valued well below $100 million. That's the kind of microcap opportunity I absolutely love!
Q: Investorideas.com
With all the government incentives and funding from this administration, how much of a role does government play for you when you look at a sector or an individual stock?
A: Josh Levine, MicroCap Investor
First, it's important to point out that the oil and nuclear industries have enjoyed massive government subsidies forever. So it's totally ridiculous when some folks get all bent out of shape and complain about the unfair advantages for renewable energy.
Now, as for the role government plays, I would say that it is a factor on the sector level, especially as it concerns solar subsidies in the U.S., Europe and elsewhere. But as we've seen, it's tough to bet on companies when from year to year you don't know what's going to happen regarding tax credits and other such things.
On the other hand, government R&D grants serve a great purpose for small companies since these funds essentially cover the costs for specific projects and enable firms with limited resources to explore technologies that they may otherwise have to put on the back burner.
There is one cleantech company in the MicroCap Investor portfolio that has benefitted considerably from government grants and the nice thing for shareholders is that any value created by these projects stays with the company.
On a final note, the government's role in basic scientific research has always been very fundamental for U.S. economic growth and that's one area that the Feds should continue to focus on. This is especially vital for energy technologies since venture capitalists and other investors don't have the patience or staying power required to take these technologies from lab to market.
Q: Investorideas.com
Within cleantech there are a lot of sub-sectors from smart grid to solar to wind to energy efficiency and others; what are you focusing on and why?
A: Josh Levine, MicroCap Investor
All of the above, but I'm especially looking at companies that solve big problems with elegant and cost-efficient solutions. There's got to be a powerful value proposition, adoption by key customers, multi-billion dollar markets, and fast-growing demand on a global scale.
There a wonderful opportunities in every segment of cleantech, but at the small company level an investor really needs to understand the dynamics of technologies and markets, not to mention to be able to evaluate management teams.
In the MicroCap Investor portfolio the cleantech companies are involved in energy storage, LED and other advanced lighting, equipment for large-scale solar projects, bioplastics, technologies for increasing the efficiency of the energy grid, and more.
I'm focusing on these companies because they could deliver profits of 100% to 1,000% over the next several years. In fact, I recently sold half of our position in one of these stocks to capture a 138% profit -- and that's just a small taste of what's ahead.
Q: Investorideas.com
What percentage of your portfolio is in the cleantech space currently and are you looking to add more companies in the space over this year?
A: Josh Levine, MicroCap Investor
About one-third of the MicroCap Investor portfolio is devoted to cleantech companies, and I've got several top prospects in my sights. It's tough to predict, but I suspect I'll be adding at least a couple of more cleantech plays to our portfolio this year.
It's really a matter of quality, not quantity, and I am extremely bullish on the current group we have today. Still, cleantech is a ripe sector and it will yield tremendous opportunities year after year for a very long time. Every growth-oriented investor should make sure a healthy portion of his or her equities portfolio is allocated to cleantech.
Josh Levine’s MicroCap Investor http://www.levinesmicrocapinvestor.com
Levine's MicroCap Investor delves deep into the world of small stocks to identify big winners, targeting innovative companies on the path of the new and revolutionary.
The strategy for MicroCap Investor is simple: to focus on small, innovative companies representing the best pure plays in the fast-growing waves of change in biotechnology, cleantech, and emerging IT.
About Josh Levine
Levine has 25 years of senior-level experience in analyzing technology trends and investing in top-performing micro- and small-cap stocks. He excels at assessing management teams and evaluating new innovations and their impact on corporate valuations.
More on Levine’s bio: http://www.levinesmicrocapinvestor.com/aboutus/
To learn more about this and the other outstanding investment opportunities in the MicroCap Investor portfolio, subscribe now.
http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com has partnered with Josh Levine and MicroCap Investor as part of its mission to provide investors with research tools to explore the world of small stocks. The InvestorIdeas.com team operates this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research portal, with resources covering high-growth sectors including technology, biotech and cleantech.
Levine’s Microcap Investor
Contact us
admin@levinesmicrocapinvestor.com
800 665 0411
New York, NY, Point Roberts WA, March 9, 2011 – Investorideas.com, a leader in cleantech stock research releases a recent Q&A with Josh Levine of the MicroCap Investor newsletter, discussing his cleantech investment outlook and strategy.
Investorideas.com Cleantech Interview:
Q: Investorideas.com
Josh, with oil prices surging above $100, cleantech is getting a lot more attention again from Wall Street and independent investors. I know you look at the long term investment picture, so what do you think is driving cleantech and what is your outlook for opportunities in this sector?
A: Josh Levine, MicroCap Investor http://www.levinesmicrocapinvestor.com/
Let's first qualify what is meant by the term cleantech. Cleantech is often used interchangeably with green technologies and alternative energy, but it seems to be the one that's emerged to encompass all these things. Cleantech essentially covers technologies that are more energy-efficient than conventional technologies and offer more environmentally-friendly alternatives to fossil-fuel-driven energy applications.
Broadly speaking, the world is always moving towards more efficient use of resources. Year after year and decade after decade, we manage to get more out of a given amount of resources. The first industrial revolution was powered by coal and though it provided tremendous gains in production, the pollution negatively impacted the quality of life and health of millions of people.
In the past century, while coal continued to have a prominent role, oil reigned as the fuel of choice because its energy density is so high, it was incredibly abundant, and it's easy to transport. The downside is that the oil supply is finite and that the burning of it leaves an undesirable byproduct. Today, it's becoming increasingly more costly to find and produce new oil -- and that's critical in the energy equation.
This brings us to cleantech opportunities, which are only just emerging after very long periods of incubation in research and development. What's happening today is a huge shift in the consciousness of governments, corporations and consumers. Of course lots of people are talking about energy efficiency, but there are also many now taking action on all levels.
Several things are driving this shift toward cleantech including climate change, the fear of running out of global oil supplies, rising world population and the limits of natural resources, higher energy costs, and environmental concerns. And then there's the surging demand from China. That's a pretty powerful mix. And when we combine these forces with the progress being made in new energy technologies, investors have a remarkable opportunity for profits.
The first electric cars are hitting the road this year after several years of hybrids, and the prospects for broad adoption over the next several years are very promising. With this comes the need for infrastructure to support car charging and that will spawn huge investments in the electric grid and networks to support these new vehicles around the U.S. and all over the world.
Of course solar and wind will continue to grow as their costs approach parity with conventional energy and they address important niches in the energy sphere. Additionally, there are so many other technologies that are part of the cleantech ecosystem and critical to the development of these markets, including batteries, fuel cells, inverters, demand response and energy management systems, ultracapacitors, superconductor cables and so much more.
To succeed in cleantech, investors really need to stay focused on the bigger picture and to be patient. The energy space moves far slower than, for example, the IT world, so developments unfold at a different rate. But once these technologies start gaining market traction, the valuations of the leading small innovative cleantech companies will generate fantastic returns for investors who got an early start.
Q: Investorideas.com
You recently just added a new cleantech stock to your portfolio. Can you give us some insight as to what qualified this particular stock based on your investing model?
A: Josh Levine, MicroCap Investor
My latest recommendation in unusual company which has developed and commercialized environmentally safe alternatives to plastics used for food containers, utensils, product wraps, as well as a wide range of parts in autos and many other things. Importantly, it meets all of my most important criteria for a great microcap investment.
As a cleantech play, this company's biodegradeable and completely safe products can replace petroleum-based polypropylene packaging. The result is less use of oil and a better outcome for the environment. It's a strong proposition.
It's a classic microcap story with all of the fundamentals in place for soaring growth -- a unique technology platform that's been validated by major customers worldwide, an experienced and proven management team, and powerful market drivers bolstered by increasing demand.
This company is addressing markets representing annual sales in the tens of billions of dollars, it has proven technology and products that are being rapidly adopted by large corporate customers, it has manufacturing capacity to scale several times current production, and its products are already on parity with polypropylene now that oil prices are north of $100.
In 2010, sales revenue for this company was $6.3 million, a 133% increase versus 2009, and projected revenue for the 2011 full year is between $24 million and $32 million -- a whopping 300% to 400% increase over 2010!
With all this going for it, this company is still valued well below $100 million. That's the kind of microcap opportunity I absolutely love!
Q: Investorideas.com
With all the government incentives and funding from this administration, how much of a role does government play for you when you look at a sector or an individual stock?
A: Josh Levine, MicroCap Investor
First, it's important to point out that the oil and nuclear industries have enjoyed massive government subsidies forever. So it's totally ridiculous when some folks get all bent out of shape and complain about the unfair advantages for renewable energy.
Now, as for the role government plays, I would say that it is a factor on the sector level, especially as it concerns solar subsidies in the U.S., Europe and elsewhere. But as we've seen, it's tough to bet on companies when from year to year you don't know what's going to happen regarding tax credits and other such things.
On the other hand, government R&D grants serve a great purpose for small companies since these funds essentially cover the costs for specific projects and enable firms with limited resources to explore technologies that they may otherwise have to put on the back burner.
There is one cleantech company in the MicroCap Investor portfolio that has benefitted considerably from government grants and the nice thing for shareholders is that any value created by these projects stays with the company.
On a final note, the government's role in basic scientific research has always been very fundamental for U.S. economic growth and that's one area that the Feds should continue to focus on. This is especially vital for energy technologies since venture capitalists and other investors don't have the patience or staying power required to take these technologies from lab to market.
Q: Investorideas.com
Within cleantech there are a lot of sub-sectors from smart grid to solar to wind to energy efficiency and others; what are you focusing on and why?
A: Josh Levine, MicroCap Investor
All of the above, but I'm especially looking at companies that solve big problems with elegant and cost-efficient solutions. There's got to be a powerful value proposition, adoption by key customers, multi-billion dollar markets, and fast-growing demand on a global scale.
There a wonderful opportunities in every segment of cleantech, but at the small company level an investor really needs to understand the dynamics of technologies and markets, not to mention to be able to evaluate management teams.
In the MicroCap Investor portfolio the cleantech companies are involved in energy storage, LED and other advanced lighting, equipment for large-scale solar projects, bioplastics, technologies for increasing the efficiency of the energy grid, and more.
I'm focusing on these companies because they could deliver profits of 100% to 1,000% over the next several years. In fact, I recently sold half of our position in one of these stocks to capture a 138% profit -- and that's just a small taste of what's ahead.
Q: Investorideas.com
What percentage of your portfolio is in the cleantech space currently and are you looking to add more companies in the space over this year?
A: Josh Levine, MicroCap Investor
About one-third of the MicroCap Investor portfolio is devoted to cleantech companies, and I've got several top prospects in my sights. It's tough to predict, but I suspect I'll be adding at least a couple of more cleantech plays to our portfolio this year.
It's really a matter of quality, not quantity, and I am extremely bullish on the current group we have today. Still, cleantech is a ripe sector and it will yield tremendous opportunities year after year for a very long time. Every growth-oriented investor should make sure a healthy portion of his or her equities portfolio is allocated to cleantech.
Josh Levine’s MicroCap Investor http://www.levinesmicrocapinvestor.com
Levine's MicroCap Investor delves deep into the world of small stocks to identify big winners, targeting innovative companies on the path of the new and revolutionary.
The strategy for MicroCap Investor is simple: to focus on small, innovative companies representing the best pure plays in the fast-growing waves of change in biotechnology, cleantech, and emerging IT.
About Josh Levine
Levine has 25 years of senior-level experience in analyzing technology trends and investing in top-performing micro- and small-cap stocks. He excels at assessing management teams and evaluating new innovations and their impact on corporate valuations.
More on Levine’s bio: http://www.levinesmicrocapinvestor.com/aboutus/
To learn more about this and the other outstanding investment opportunities in the MicroCap Investor portfolio, subscribe now.
http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com has partnered with Josh Levine and MicroCap Investor as part of its mission to provide investors with research tools to explore the world of small stocks. The InvestorIdeas.com team operates this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research portal, with resources covering high-growth sectors including technology, biotech and cleantech.
Levine’s Microcap Investor
Contact us
admin@levinesmicrocapinvestor.com
800 665 0411
Water Stocks News; Wescorp's (OTCBB:WSCE) Completes the Commissioning of its 10,000 bpd H2Omaxx Mobile Water Remediation Unit
CALGARY, ALBERTA - March 8, 2011 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE) today announced it has completed the commissioning of its 10,000 barrel-per-day (bpd) mobile H(2)Omaxx unit at K-Line Trailers: www.klinetrailers.com. This new, second generation unit is now ready for commercial deployment.
"Importantly, the functioning of a 10,000 bpd capacity unit demonstrates the scalability of the H(2)Omaxx technology," said Robert Power, Executive Chairman of Wescorp Energy Inc. "Scalability is a major hurdle for new technologies, and is a barrier to overcome for commercial success. The 10,000 bpd capacity unit will also respond to industry feedback that an enhanced treatment capacity is desired for larger volume fluid treatment opportunities."
Because of the interest generated by Wescorp's sales team and K-Line Trailers, Wescorp will be demonstrating the 10,000 bpd unit to a number of potential engineering, environmental and oil and gas clients in Vancouver, Edmonton and Calgary. Upon completion of these demonstrations, Wescorp plans to move the unit to Saskatchewan, as previously announced.
The self-contained, mobile H(2)Omaxx unit is designed to be easily transported to remote locations. K-Line Trailers has designed and built a customized trailer unit which is fully self-contained, fully automated and capable of easy integration into a customer's operations, leaving a small footprint on the client's site.
This next generation unit also has its own storage, separation and containment tanks, micro-aeration generators, firmware and computer automation technology to allow water remediation and oil recovery with minimal human supervision.
The unit will be available for customer and investor demonstrations. If you are interested in a demonstration of the mobile 10,000 bpd H(2)Omaxx unit, please contact Patricia Lew-Lapointe at 1-877-247-1975 for further details on schedule and availability.
About the H(2)Omaxx Technology
H(2)Omaxx utilizes proprietary next generation aeration technology to clean and separate oil and solids from water. It is a proven safe, effective, economical and environmentally-friendly process. Independent test results have shown the H(2)0maxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.
Terri MacInnis, Dir. of Investor Relations
818-379-8500
terri@bibimac.com
CALGARY, ALBERTA - March 8, 2011 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE) today announced it has completed the commissioning of its 10,000 barrel-per-day (bpd) mobile H(2)Omaxx unit at K-Line Trailers: www.klinetrailers.com. This new, second generation unit is now ready for commercial deployment.
"Importantly, the functioning of a 10,000 bpd capacity unit demonstrates the scalability of the H(2)Omaxx technology," said Robert Power, Executive Chairman of Wescorp Energy Inc. "Scalability is a major hurdle for new technologies, and is a barrier to overcome for commercial success. The 10,000 bpd capacity unit will also respond to industry feedback that an enhanced treatment capacity is desired for larger volume fluid treatment opportunities."
Because of the interest generated by Wescorp's sales team and K-Line Trailers, Wescorp will be demonstrating the 10,000 bpd unit to a number of potential engineering, environmental and oil and gas clients in Vancouver, Edmonton and Calgary. Upon completion of these demonstrations, Wescorp plans to move the unit to Saskatchewan, as previously announced.
The self-contained, mobile H(2)Omaxx unit is designed to be easily transported to remote locations. K-Line Trailers has designed and built a customized trailer unit which is fully self-contained, fully automated and capable of easy integration into a customer's operations, leaving a small footprint on the client's site.
This next generation unit also has its own storage, separation and containment tanks, micro-aeration generators, firmware and computer automation technology to allow water remediation and oil recovery with minimal human supervision.
The unit will be available for customer and investor demonstrations. If you are interested in a demonstration of the mobile 10,000 bpd H(2)Omaxx unit, please contact Patricia Lew-Lapointe at 1-877-247-1975 for further details on schedule and availability.
About the H(2)Omaxx Technology
H(2)Omaxx utilizes proprietary next generation aeration technology to clean and separate oil and solids from water. It is a proven safe, effective, economical and environmentally-friendly process. Independent test results have shown the H(2)0maxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.
Terri MacInnis, Dir. of Investor Relations
818-379-8500
terri@bibimac.com
Visit the WSCE showcase profile at Investorideas.com
Request News and Info on WSCE
Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
Request News and Info on WSCE
Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
Tuesday, March 08, 2011
Biotech Stocks; Aethlon Medical (OTCBB: AEMD) Receives FDA Approval to Export its Hemopurifier to India
Visit this company: http://www.aethlonmedical.com/
SAN DIEGO - March 8, 2011 (Investorideas.com Newswire) - Aethlon Medical, Inc. (OTC Bulletin Board:AEMD.ob), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Aethlon's request to export its Hemopurifier® medical device to India.
The FDA's approval was granted under Section 801 (e) of the Federal Food, Drug, and Cosmetic Act, as amended (the Act). Section 801 (e) of the Act covers class III medical devices, such as the Hemopurifier®, that have not yet received an approved Premarket Approval in the US by the FDA. Section 801 (e) applies to medical devices that are acceptable to the importing country and that are manufactured under the FDA's Good Manufacturing Practices.
"The granting of our export license by FDA represents a critical step in our strategy to initiate future commercialization of our Hemopurifier® in India," stated Jim Joyce, Aethlon Chairman and CEO.
Aethlon is currently conducting a clinical study entitled: "Use of the Aethlon Hemopurifier® in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy" at the Medicity Institute (Medicity) near Delhi, India. The Medicity is a $360 million multi-specialty medical institute recently established on a 43-acre campus to be a premier center of medical tourism in India. A clinical goal of the Aethlon-Medicity study will be to demonstrate that the Hemopurifier® is able to accelerate the benefit of HCV standard of care (SOC) drug regimens. Therapeutic filtration at the outset of SOC improves early virus reduction kinetics to levels associated with that of patients most likely to achieve a sustained viral response, which is the goal of HCV therapy. Additionally, lower quantities of HCV in circulation at the outset of SOC correlate with increased cure rates. Upon demonstration of treatment efficacy, Aethlon plans to commence commercialization of its Hemopurifier® in India.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www
Visit this company: http://www.aethlonmedical.com/
SAN DIEGO - March 8, 2011 (Investorideas.com Newswire) - Aethlon Medical, Inc. (OTC Bulletin Board:AEMD.ob), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Aethlon's request to export its Hemopurifier® medical device to India.
The FDA's approval was granted under Section 801 (e) of the Federal Food, Drug, and Cosmetic Act, as amended (the Act). Section 801 (e) of the Act covers class III medical devices, such as the Hemopurifier®, that have not yet received an approved Premarket Approval in the US by the FDA. Section 801 (e) applies to medical devices that are acceptable to the importing country and that are manufactured under the FDA's Good Manufacturing Practices.
"The granting of our export license by FDA represents a critical step in our strategy to initiate future commercialization of our Hemopurifier® in India," stated Jim Joyce, Aethlon Chairman and CEO.
Aethlon is currently conducting a clinical study entitled: "Use of the Aethlon Hemopurifier® in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy" at the Medicity Institute (Medicity) near Delhi, India. The Medicity is a $360 million multi-specialty medical institute recently established on a 43-acre campus to be a premier center of medical tourism in India. A clinical goal of the Aethlon-Medicity study will be to demonstrate that the Hemopurifier® is able to accelerate the benefit of HCV standard of care (SOC) drug regimens. Therapeutic filtration at the outset of SOC improves early virus reduction kinetics to levels associated with that of patients most likely to achieve a sustained viral response, which is the goal of HCV therapy. Additionally, lower quantities of HCV in circulation at the outset of SOC correlate with increased cure rates. Upon demonstration of treatment efficacy, Aethlon plans to commence commercialization of its Hemopurifier® in India.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www
Wind Stocks Trading Alert; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Up on Patent News
Point Roberts, WA � March 7, 2011 - Investorideas.com, a leader in cleantech stock research, releases a trading alert for Clean Wind Energy Tower, Inc. (OTCBB:CWET). The stock is trading at $0.25, up 0.05 (25.00%) on patent news.
The Company announced today it had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
News: http://www.investorideas.com/CO/CWE/news/2011/03071.asp
Clean Wind Energy Tower, Inc. (OTCBB:CWET) www.cleanwindenergytower.com
Clean Wind Energy, Inc. a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large “Downdraft Towers” that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity.
Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Dual Renewable Energy Technology
The Downdraft Tower is a hollow cylinder with a water spray system at the top. Pumps deliver water to the top of the Downdraft Tower to spray a fine mist across the entire opening. The water evaporates and cools the hot dry air at the top. The cooled air is more dense and heavier than the outside warmer air and falls through the cylinder at speeds up to 50 mph, driving the turbines located at the base of the structure. The turbines are attached to generators to produce electricity. The exterior of the Downdraft Tower is constructed with vertical “wind vanes” that run the entire length of the structure. The Downdraft Tower's vanes capture the prevailing wind and channel it through a separate system of tunnels to turn turbines attached to generators that produce additional electrical power. This dual renewable energy resource enhances the capability and productivity of the Clean Wind system.
Environmental
Various parties in the United States and other nations are pursuing clean energy solutions that use efficient and cost- effective renewable resources to serve society while avoiding the adverse effects associated with fossil and nuclear fuels, and also the obvious limitations of solar collectors that work only when the sun shines or wind turbines that work only when the wind blows.
The Downdraft Tower has the capability of being operated with virtually no carbon footprint, fuel consumption, or waste production and this technology has the potential to generate clean, cost effective and efficient electrical power without the damaging effects caused by using fossil or nuclear fuels, and other conventional power sources. The Company also believes that increasing emphasis on green technologies and governmental incentives in the energy industry should have a positive long-term effect on the Company's planned business and the wind energy industry in general.
Partners
The Company has entered into a number of agreements with potential partners to meet the development aspects of the tower. Specifically, three of the largest companies in the world are working with clean wind providing final bids to meet the tower's specifications.
Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Contact the company:
410-972-4713
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on Clean Wind Energy,
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 shares 144) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information about Investorideas.com green stocks contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Point Roberts, WA � March 7, 2011 - Investorideas.com, a leader in cleantech stock research, releases a trading alert for Clean Wind Energy Tower, Inc. (OTCBB:CWET). The stock is trading at $0.25, up 0.05 (25.00%) on patent news.
The Company announced today it had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
News: http://www.investorideas.com/CO/CWE/news/2011/03071.asp
Clean Wind Energy Tower, Inc. (OTCBB:CWET) www.cleanwindenergytower.com
Clean Wind Energy, Inc. a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large “Downdraft Towers” that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity.
Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Dual Renewable Energy Technology
The Downdraft Tower is a hollow cylinder with a water spray system at the top. Pumps deliver water to the top of the Downdraft Tower to spray a fine mist across the entire opening. The water evaporates and cools the hot dry air at the top. The cooled air is more dense and heavier than the outside warmer air and falls through the cylinder at speeds up to 50 mph, driving the turbines located at the base of the structure. The turbines are attached to generators to produce electricity. The exterior of the Downdraft Tower is constructed with vertical “wind vanes” that run the entire length of the structure. The Downdraft Tower's vanes capture the prevailing wind and channel it through a separate system of tunnels to turn turbines attached to generators that produce additional electrical power. This dual renewable energy resource enhances the capability and productivity of the Clean Wind system.
Environmental
Various parties in the United States and other nations are pursuing clean energy solutions that use efficient and cost- effective renewable resources to serve society while avoiding the adverse effects associated with fossil and nuclear fuels, and also the obvious limitations of solar collectors that work only when the sun shines or wind turbines that work only when the wind blows.
The Downdraft Tower has the capability of being operated with virtually no carbon footprint, fuel consumption, or waste production and this technology has the potential to generate clean, cost effective and efficient electrical power without the damaging effects caused by using fossil or nuclear fuels, and other conventional power sources. The Company also believes that increasing emphasis on green technologies and governmental incentives in the energy industry should have a positive long-term effect on the Company's planned business and the wind energy industry in general.
Partners
The Company has entered into a number of agreements with potential partners to meet the development aspects of the tower. Specifically, three of the largest companies in the world are working with clean wind providing final bids to meet the tower's specifications.
Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Contact the company:
410-972-4713
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on Clean Wind Energy,
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 shares 144) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information about Investorideas.com green stocks contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Wind Stocks; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Unique Hydraulic System Patent
ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
John W. Hanback, Chief Technology Officer of CWET, stated, "We are extremely excited and positive about the application we submitted to the USPTO on February 25, 2011. As required our patent council diligently and extensively searched multiple patent data bases and resources as needed to present a comprehensive analysis as a basis for the patent examiners own due diligence and review. The technological concepts and applications claimed and embodied within this patent provide significant benefits toward enhancing the overall efficient power generation we will be providing our customers. We will continue to file multiple patent applications that are being readied, of which provisional patent applications already exist, under this beneficial accelerated review protocol."
Ronald W. Pickett, President and CEO of CWET, stated, "Clean Wind Energy Tower, Inc. continues to cultivate innovative technological imperatives in addition to our already advanced wind energy structural designs and enhanced power generation methodologies. We applaud the USPTO and our Government for waiving the petition filing fee, for cases based on critical claimed subject matter directed to energy, among other categories, within this accelerated format. To reiterate our CTO's statement, this application is but the first of many that we will file, focused on our leadership and value proposition for producing clean renewable fuel resources."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
John W. Hanback, Chief Technology Officer of CWET, stated, "We are extremely excited and positive about the application we submitted to the USPTO on February 25, 2011. As required our patent council diligently and extensively searched multiple patent data bases and resources as needed to present a comprehensive analysis as a basis for the patent examiners own due diligence and review. The technological concepts and applications claimed and embodied within this patent provide significant benefits toward enhancing the overall efficient power generation we will be providing our customers. We will continue to file multiple patent applications that are being readied, of which provisional patent applications already exist, under this beneficial accelerated review protocol."
Ronald W. Pickett, President and CEO of CWET, stated, "Clean Wind Energy Tower, Inc. continues to cultivate innovative technological imperatives in addition to our already advanced wind energy structural designs and enhanced power generation methodologies. We applaud the USPTO and our Government for waiving the petition filing fee, for cases based on critical claimed subject matter directed to energy, among other categories, within this accelerated format. To reiterate our CTO's statement, this application is but the first of many that we will file, focused on our leadership and value proposition for producing clean renewable fuel resources."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Visit the CWET showcase profile at Investorideas.com
Request News and Info on CWET
Disclosure, Disclaimer/ CWET is a paid advertising client on Investorideas.com and our Renewable Energy portals. (one thousand five hundred, 100,000 144 shares)
Request News and Info on CWET
Disclosure, Disclaimer/ CWET is a paid advertising client on Investorideas.com and our Renewable Energy portals. (one thousand five hundred, 100,000 144 shares)
Mining Stocks; YALE (TSX-V: YLL) Stakes Additional Land at Los Amoles � Samples 432 g/t Silver Over 2.2 M
March 7, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report it has applied for, by staking, an additional land adjoining the Los Amoles Property. Work at Los Amoles is being done by Yale on behalf of Sonora Resources Corp. (previously Nature's Call), who has an option to earn a 70% interest in the property.
This new land package is 1,960 hectares (19.6 square kilometres) in size and covers extensions of the known mineralizing system to the east and south of the main target area of the property.
Reconnaissance sampling aimed at evaluating the potential continuation of the greater than 800 metres of strike extension of the mineralization identified to date returned very encouraging values of:
About the Los Amoles Property:
The early stage wholly owned 16.3 square kilometre Los Amoles Property is located approximately 150 kilometres northeast of the Hermosillo, Sonora State, Mexico. The property is 10 kilometres northeast of the La Caridad Mine, operated by Grupo Mexico, which is one of the largest mining and processing complexes in Mexico.
Sonora Resources has an option to earn a 70% interest in the property by paying to Yale US $ 50,000 (received), spending US $ 900,000 on exploration expenditures and issuing 1,000,000 shares (200,000 have been received) to Yale over three years.
Samples from Los Amoles were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold and silver analyses were performed by 30 gram fire assay with an AA finish. Samples with greater than 100 g/t silver were re-assayed using gravimetric methods.
Ian Foreman, P.Geo., is Yale Resources' Qualified Person, as defined by National Instrument 43-101. The Los Amoles property is an early stage project that requires additional sampling and geological mapping to fully determine the project's potential.
About Yale Resources:
Yale Resources is an exploration and development company concentrating in northwestern Mexico. Utilizing the joint venture business model, Yale is able to maximize its exposure to discovery while minimizing exploration risk. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects. Yale has four projects under option to value added partners with commitments for approximately $1.0M in expenditures during the next 12 months.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
March 7, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report it has applied for, by staking, an additional land adjoining the Los Amoles Property. Work at Los Amoles is being done by Yale on behalf of Sonora Resources Corp. (previously Nature's Call), who has an option to earn a 70% interest in the property.
This new land package is 1,960 hectares (19.6 square kilometres) in size and covers extensions of the known mineralizing system to the east and south of the main target area of the property.
Reconnaissance sampling aimed at evaluating the potential continuation of the greater than 800 metres of strike extension of the mineralization identified to date returned very encouraging values of:
- 50 cm grading 0.41 g/t gold and 215.6 g/t silver, and
- 2.20 m averaging 0.39 g/t gold and 432.0 g/t silver.
About the Los Amoles Property:
The early stage wholly owned 16.3 square kilometre Los Amoles Property is located approximately 150 kilometres northeast of the Hermosillo, Sonora State, Mexico. The property is 10 kilometres northeast of the La Caridad Mine, operated by Grupo Mexico, which is one of the largest mining and processing complexes in Mexico.
Sonora Resources has an option to earn a 70% interest in the property by paying to Yale US $ 50,000 (received), spending US $ 900,000 on exploration expenditures and issuing 1,000,000 shares (200,000 have been received) to Yale over three years.
Samples from Los Amoles were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold and silver analyses were performed by 30 gram fire assay with an AA finish. Samples with greater than 100 g/t silver were re-assayed using gravimetric methods.
Ian Foreman, P.Geo., is Yale Resources' Qualified Person, as defined by National Instrument 43-101. The Los Amoles property is an early stage project that requires additional sampling and geological mapping to fully determine the project's potential.
About Yale Resources:
Yale Resources is an exploration and development company concentrating in northwestern Mexico. Utilizing the joint venture business model, Yale is able to maximize its exposure to discovery while minimizing exploration risk. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects. Yale has four projects under option to value added partners with commitments for approximately $1.0M in expenditures during the next 12 months.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Energy Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling Underway at NOS227 Well on North Oklahoma Oil Project
SCOTTSDALE, AZ � March 7, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce today that the NOS227 Well at the North Oklahoma Project located in Payne County, Oklahoma has spud and the well is drilling ahead.
It is anticipated that NOS227 will reach its planned depth of 4,000 feet in seven days. As previously reported, the primary objective is the productive Woodford and Mississippi Formations with secondary opportunities identified in the Miesner and Skinner Sands. The location exhibits the potential for 80 plus feet of pay from the known productive formations which offset to the northwest and southeast.
American Petro-Hunter is currently producing oil from the Woodford and the Mississippian at its No.1 and NOJ26 wells. The new NOS227 is a direct offset to the recently completed commercial oil well at the NOJ26 location and takes advantage of a favorable oil producing geological trend up dip and to the west offsetting existing production.
A successful Mississippian-Woodford well with comingled production from both formations is estimated to offer a 150-250 BPD potential. American Petro-Hunter has a 50% interest in the well.
Company President Robert McIntosh states, "The NOS227 location offers targets in the Mississippian and Woodford formations which are the current focus of all the considerable recent E&P excitement in Payne County. As the play in Northern Oklahoma unfolds throughout the year ahead, we anticipate announcements of big discovery wells from horizontal drilling in the area that rival some of the early Bakken Play results. The Company is strategically positioned with leases and locations that have prime Mississippian-Woodford access that will allow us to participate with drilling operations right in the heart of the play."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
SCOTTSDALE, AZ � March 7, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce today that the NOS227 Well at the North Oklahoma Project located in Payne County, Oklahoma has spud and the well is drilling ahead.
It is anticipated that NOS227 will reach its planned depth of 4,000 feet in seven days. As previously reported, the primary objective is the productive Woodford and Mississippi Formations with secondary opportunities identified in the Miesner and Skinner Sands. The location exhibits the potential for 80 plus feet of pay from the known productive formations which offset to the northwest and southeast.
American Petro-Hunter is currently producing oil from the Woodford and the Mississippian at its No.1 and NOJ26 wells. The new NOS227 is a direct offset to the recently completed commercial oil well at the NOJ26 location and takes advantage of a favorable oil producing geological trend up dip and to the west offsetting existing production.
A successful Mississippian-Woodford well with comingled production from both formations is estimated to offer a 150-250 BPD potential. American Petro-Hunter has a 50% interest in the well.
Company President Robert McIntosh states, "The NOS227 location offers targets in the Mississippian and Woodford formations which are the current focus of all the considerable recent E&P excitement in Payne County. As the play in Northern Oklahoma unfolds throughout the year ahead, we anticipate announcements of big discovery wells from horizontal drilling in the area that rival some of the early Bakken Play results. The Company is strategically positioned with leases and locations that have prime Mississippian-Woodford access that will allow us to participate with drilling operations right in the heart of the play."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Monday, March 07, 2011
NASDAQ Leaders; (NASDAQ: ATRN) Trading at 5.68, up 2.70 90.28%,
POINT ROBERTS, Wash., March 7, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on trading leaders on the NASDAQ. Direct-to-consumer company, Atrinsic, Inc. $ (NASDAQ: ATRN) is the top gainer, currently trading at 5.68, up 2.70 90.28% 875,217. Energy investors are also seeing strong gains in select stocks as oil trades above $105.
Trading Close-Up
Company Last Sale* Change Net / % Share Volume
Atrinsic, Inc. $ (NASDAQ: ATRN) trading at 5.68, up 2.70 90.28% 875,217
Synthesis Energy Systems, Inc. (NASDAQ: SYMX) trading at $ 2.04, up 0.68 50.00% 3,671,658
TomoTherapy Incorporated (NASDAQ: TOMO) trading at $ 4.56, up 0.89 24.25% 12,219,581
RAM Energy Resources, Inc. (NASDAQ: RAME) trading at $ 2.44, up 0.42 20.79% 11,249,507
Market Snapshot (at time of release)
Dow 12,067.37 -102.51 -0.84%
Nasdaq 2,736.10 -48.57 -1.74%
S&P 500 1,307.39 -13.76 -1.04%
10 Yr Bond (%) 3.5010% +0.0090
Oil 105.37 +0.95 +0.91%
Company Snapshot- (NASDAQ:ATRN)
Atrinsic, Inc. is a marketer of direct-to-consumer subscription products and an Internet search-marketing agency. Atrinsic sells entertainment and lifestyle subscription products directly to consumers, which are marketed through the Internet. Atrinsic also sells Internet marketing services to its corporate and advertising clients. Atrinsic has developed its marketing media network, consisting of web sites, proprietary content and licensed media, to attract consumers, corporate partners and advertisers. Atrinsic believes its marketing media network and proprietary technology allow it to cost-effectively acquire consumers for its products and for its corporate partners and advertisers.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content. Investor Ideas (and portals within the hub) was one of the first online investing and business resources providing in-depth information, news and stock directories in renewable energy, homeland security and water sectors. InvestorIdeas.com features over twenty industry sectors and global markets including China, India, Middle East and Australia.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
POINT ROBERTS, Wash., March 7, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on trading leaders on the NASDAQ. Direct-to-consumer company, Atrinsic, Inc. $ (NASDAQ: ATRN) is the top gainer, currently trading at 5.68, up 2.70 90.28% 875,217. Energy investors are also seeing strong gains in select stocks as oil trades above $105.
Trading Close-Up
Company Last Sale* Change Net / % Share Volume
Atrinsic, Inc. $ (NASDAQ: ATRN) trading at 5.68, up 2.70 90.28% 875,217
Synthesis Energy Systems, Inc. (NASDAQ: SYMX) trading at $ 2.04, up 0.68 50.00% 3,671,658
TomoTherapy Incorporated (NASDAQ: TOMO) trading at $ 4.56, up 0.89 24.25% 12,219,581
RAM Energy Resources, Inc. (NASDAQ: RAME) trading at $ 2.44, up 0.42 20.79% 11,249,507
Market Snapshot (at time of release)
Dow 12,067.37 -102.51 -0.84%
Nasdaq 2,736.10 -48.57 -1.74%
S&P 500 1,307.39 -13.76 -1.04%
10 Yr Bond (%) 3.5010% +0.0090
Oil 105.37 +0.95 +0.91%
Company Snapshot- (NASDAQ:ATRN)
Atrinsic, Inc. is a marketer of direct-to-consumer subscription products and an Internet search-marketing agency. Atrinsic sells entertainment and lifestyle subscription products directly to consumers, which are marketed through the Internet. Atrinsic also sells Internet marketing services to its corporate and advertising clients. Atrinsic has developed its marketing media network, consisting of web sites, proprietary content and licensed media, to attract consumers, corporate partners and advertisers. Atrinsic believes its marketing media network and proprietary technology allow it to cost-effectively acquire consumers for its products and for its corporate partners and advertisers.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content. Investor Ideas (and portals within the hub) was one of the first online investing and business resources providing in-depth information, news and stock directories in renewable energy, homeland security and water sectors. InvestorIdeas.com features over twenty industry sectors and global markets including China, India, Middle East and Australia.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Oil and Gas Stocks Directory Grows to over 700 Stocks; Includes Bakken Stocks, Woodford Shale and Oil Sands Stocks
POINT ROBERTS, Wash. - March 4, 2011 - www.InvestorIdeas.com, a leader in sector research for investors, including energy stocks, updates the oil and gas stocks directory for March, now listing over 700 publicly traded oil and gas stocks. As oil continues to rise, hitting $103. the energy stocks directory is one of the most visited pages at Investorideas.com.
The oil and gas stocks directory features over seven hundred stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. The directory also features a section on Bakken stocks and oil sands stocks.
Preview the directory here: http://www.investorideas.com/OGSN/Stock_List.asp
Featured Energy Stock:
American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Investorideas.com members can access all energy stock directories, in addition to biotech, nanotech, water, defense and the newly added tech stocks for cloud computing and social network stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclosure: American Petro-Hunter, Inc. (OTC.BB: AAPH) is a paid advertising showcase company on Investorideas.com ( two thousand per month blended average)
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
POINT ROBERTS, Wash. - March 4, 2011 - www.InvestorIdeas.com, a leader in sector research for investors, including energy stocks, updates the oil and gas stocks directory for March, now listing over 700 publicly traded oil and gas stocks. As oil continues to rise, hitting $103. the energy stocks directory is one of the most visited pages at Investorideas.com.
The oil and gas stocks directory features over seven hundred stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. The directory also features a section on Bakken stocks and oil sands stocks.
Preview the directory here: http://www.investorideas.com/OGSN/Stock_List.asp
Featured Energy Stock:
American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Investorideas.com energy stock directories for investors:
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Investorideas.com members can access all energy stock directories, in addition to biotech, nanotech, water, defense and the newly added tech stocks for cloud computing and social network stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclosure: American Petro-Hunter, Inc. (OTC.BB: AAPH) is a paid advertising showcase company on Investorideas.com ( two thousand per month blended average)
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Agriculture Stocks Directory added to Investor Ideas Members Content
POINT ROBERTS, Wash., March 4, 2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research, is pleased to report to recent additions to the Investor Ideas member content includes the agriculture stocks directory and the new tech stocks directory featuring cloud computing and social media stocks.
The agriculture stocks directory has been one of the most visited pages on the site for several months as global food concerns and prices rise.
Preview the agriculture stocks directory: http://www.investorideas.com/MSS/Arg_Stock_List.asp
Investor Ideas membership currently features eleven stock directories, including one of the largest green and renewable energy stocks directory online, featuring over 1200 green publicly traded companies .
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Additional stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1100 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks Directory features publicly traded defense stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory, in PDF format, includes Homeland Security Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security Stocks, Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks symbol(s), company's URL and company's description. For defense stocks followers, this is one of the most comprehensive global stock directories available to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The stock directory features water stocks ranging from desalination companies to bottled water stocks, to infrastructure, water treatment and technology as well as other sub sectors. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description. For investors following water stocks this is one of the most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. For green investors looking for opportunities in the fuel cell sector, the comprehensive global directory in PDF format provides a great research tool with hyperlinks to stocks symbol(s), company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma and Life Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory covers all sub sectors of biotech including nanotech, biodefense and stem cell stocks. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for investors The comprehensive global directory in PDF format provides a great research tool for biotechnology investors with hyperlinks to stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech companies, nanotech water and renewable energy companies and more. Directory features company description, stock symbol and hyperlink to recent quote and info, link to website and more.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
POINT ROBERTS, Wash., March 4, 2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research, is pleased to report to recent additions to the Investor Ideas member content includes the agriculture stocks directory and the new tech stocks directory featuring cloud computing and social media stocks.
The agriculture stocks directory has been one of the most visited pages on the site for several months as global food concerns and prices rise.
Preview the agriculture stocks directory: http://www.investorideas.com/MSS/Arg_Stock_List.asp
Investor Ideas membership currently features eleven stock directories, including one of the largest green and renewable energy stocks directory online, featuring over 1200 green publicly traded companies .
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Additional stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1100 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks Directory features publicly traded defense stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory, in PDF format, includes Homeland Security Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security Stocks, Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks symbol(s), company's URL and company's description. For defense stocks followers, this is one of the most comprehensive global stock directories available to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The stock directory features water stocks ranging from desalination companies to bottled water stocks, to infrastructure, water treatment and technology as well as other sub sectors. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description. For investors following water stocks this is one of the most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. For green investors looking for opportunities in the fuel cell sector, the comprehensive global directory in PDF format provides a great research tool with hyperlinks to stocks symbol(s), company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma and Life Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory covers all sub sectors of biotech including nanotech, biodefense and stem cell stocks. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for investors The comprehensive global directory in PDF format provides a great research tool for biotechnology investors with hyperlinks to stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech companies, nanotech water and renewable energy companies and more. Directory features company description, stock symbol and hyperlink to recent quote and info, link to website and more.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) to Raise $25.1 Million in Registered Direct Offering
LINCOLNSHIRE, Ill. - March 4, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately $23.8 million after deducting placement agent fees and other offering expenses. BioSante has entered into securities purchase agreements with these investors pursuant to which BioSante has agreed to sell an aggregate of approximately 12.2 million shares of its common stock and warrants to purchase up to approximately 4.0 million additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.33 of a share of common stock, will be sold for a purchase price of $2.0613, a premium to the closing price on the day before pricing.
"We are pleased to have this commitment from these new and existing institutional investors," said Stephen M. Simes, BioSante's president and chief executive officer. "This additional funding provides us with added financial power to continue to fund our ongoing LibiGel� Phase III clinical study program. We recently announced completion of enrollment in the first of the two LibiGel Phase III efficacy trials and expect to announce completion of enrollment in the second in the near future. LibiGel remains the lead pharmaceutical product in the U.S. in active development for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, and we continue to believe that LibiGel has the potential to be the first product approved by the FDA for this common and unmet medical need."
The warrants to purchase additional shares will be exercisable at an exercise price of $2.25 per share beginning immediately and will expire three years from their date of issuance. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes, including continuing to fund BioSante's LibiGel Phase III clinical study program. The offering is expected to be consummated by March 8, 2011, subject to customary closing conditions.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (NASDAQ:RODM), acted as the exclusive placement agent for the transaction. Oppenheimer & Co. Inc., Roth Capital Partners, LLC, JMP Securities LLC and Trout Capital, LLC acted as financial advisors.
Shelf registration statements relating to the shares of common stock and warrants issued in the offering (and the shares of common stock issuable upon exercise of the warrants) have been filed with the Securities and Exchange Commission (the "SEC") and declared effective. A prospectus supplement relating to the offering will be filed by BioSante with the SEC. Copies of the prospectus supplement and accompanying prospectuses may be obtained directly from BioSante by contacting BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, Illinois 60069. Copies of the final prospectus supplement and accompanying prospectuses relating to the offering also may be obtained from Rodman & Renshaw, LLC, 1251 Avenue of the Americas 20th Floor, New York, NY 10020 or by calling (212) 356-0549. This announcement is neither an offer to sell nor a solicitation of an offer to buy any shares of common stock or warrants of BioSante. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
LINCOLNSHIRE, Ill. - March 4, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately $23.8 million after deducting placement agent fees and other offering expenses. BioSante has entered into securities purchase agreements with these investors pursuant to which BioSante has agreed to sell an aggregate of approximately 12.2 million shares of its common stock and warrants to purchase up to approximately 4.0 million additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.33 of a share of common stock, will be sold for a purchase price of $2.0613, a premium to the closing price on the day before pricing.
"We are pleased to have this commitment from these new and existing institutional investors," said Stephen M. Simes, BioSante's president and chief executive officer. "This additional funding provides us with added financial power to continue to fund our ongoing LibiGel� Phase III clinical study program. We recently announced completion of enrollment in the first of the two LibiGel Phase III efficacy trials and expect to announce completion of enrollment in the second in the near future. LibiGel remains the lead pharmaceutical product in the U.S. in active development for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, and we continue to believe that LibiGel has the potential to be the first product approved by the FDA for this common and unmet medical need."
The warrants to purchase additional shares will be exercisable at an exercise price of $2.25 per share beginning immediately and will expire three years from their date of issuance. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes, including continuing to fund BioSante's LibiGel Phase III clinical study program. The offering is expected to be consummated by March 8, 2011, subject to customary closing conditions.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (NASDAQ:RODM), acted as the exclusive placement agent for the transaction. Oppenheimer & Co. Inc., Roth Capital Partners, LLC, JMP Securities LLC and Trout Capital, LLC acted as financial advisors.
Shelf registration statements relating to the shares of common stock and warrants issued in the offering (and the shares of common stock issuable upon exercise of the warrants) have been filed with the Securities and Exchange Commission (the "SEC") and declared effective. A prospectus supplement relating to the offering will be filed by BioSante with the SEC. Copies of the prospectus supplement and accompanying prospectuses may be obtained directly from BioSante by contacting BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, Illinois 60069. Copies of the final prospectus supplement and accompanying prospectuses relating to the offering also may be obtained from Rodman & Renshaw, LLC, 1251 Avenue of the Americas 20th Floor, New York, NY 10020 or by calling (212) 356-0549. This announcement is neither an offer to sell nor a solicitation of an offer to buy any shares of common stock or warrants of BioSante. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
Friday, March 04, 2011
Biotech/Pharma Stock Trading Alert; BioSante Pharmaceuticals Inc (NASDAQ:BPAX) up over 10% on News
Point Roberts, WA. - March 3, 2011 (Investorideas.com Energy stocks Newswire) - www.InvestorIdeas.com, a leader in sector stock research including biotech stocks, releases a technical stock trading alert for BioSante Pharmaceuticals Inc (NASDAQ:BPAX). The stock is currently trading at $2.27, up 0.23 (11.82%), trading as high as $2.52 in morning trading.
The stock traded up on news headline "BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study."
BPAX Stock Chart
Today's News:
Biotech/Pharma Stock News; BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
"LINCOLNSHIRE, Ill. - March 3, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent. In addition, the vaccine demonstrated a 35 percent increase in one year survival, from 63 percent to 85 percent. A new multicenter clinical study is planned to begin this year.
In the study, titled, "A Lethally Irradiated Allogeneic GM-CSF-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation," published in the February 2011 issue of Annals of Surgery, the primary endpoint was disease free survival and secondary endpoints were overall survival and toxicity, and the induction of mesothelin specific T cell responses. The median disease-free survival of patients was 17.3 months (95% CI, 14.6–22.8) with median survival of 24.8 months (95% CI, 21.2–31.6). The administration of immunotherapy was well tolerated. In addition, the postimmunotherapy induction of mesothelin-specific T cells in patients correlates with disease-free survival. The investigators concluded that "an immunotherapy approach integrated with chemoradiation is safe and effective for resected pancreas cancer."
The 60 patient Phase II study was conducted by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. The research was funded by the National Institutes of Health and other foundations. BioSante's Pancreas Cancer Vaccine is made from allogeneic pancreatic cancer cells genetically altered to produce an immune system stimulator called GM-CSF, and irradiated to prevent cell growth. BioSante already has received Orphan Drug designation from the U.S. Food & Drug Administration for the Pancreas Cancer Vaccine.”
Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03031.asp
More info: About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal : www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Contact BioSante Pharmaceuticals
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220; azachary@mckinneychicago.com
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com
Investorideas.com Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com. (one thousand per month)
Disclaimer: The following news is paid for by BPAX (one thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com to become a biotech showcase stock or research biotech stocks
800 665 0411 cvanzant@investorideas.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
Point Roberts, WA. - March 3, 2011 (Investorideas.com Energy stocks Newswire) - www.InvestorIdeas.com, a leader in sector stock research including biotech stocks, releases a technical stock trading alert for BioSante Pharmaceuticals Inc (NASDAQ:BPAX). The stock is currently trading at $2.27, up 0.23 (11.82%), trading as high as $2.52 in morning trading.
The stock traded up on news headline "BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study."
BPAX Stock Chart
Today's News:Biotech/Pharma Stock News; BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
"LINCOLNSHIRE, Ill. - March 3, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent. In addition, the vaccine demonstrated a 35 percent increase in one year survival, from 63 percent to 85 percent. A new multicenter clinical study is planned to begin this year.
In the study, titled, "A Lethally Irradiated Allogeneic GM-CSF-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation," published in the February 2011 issue of Annals of Surgery, the primary endpoint was disease free survival and secondary endpoints were overall survival and toxicity, and the induction of mesothelin specific T cell responses. The median disease-free survival of patients was 17.3 months (95% CI, 14.6–22.8) with median survival of 24.8 months (95% CI, 21.2–31.6). The administration of immunotherapy was well tolerated. In addition, the postimmunotherapy induction of mesothelin-specific T cells in patients correlates with disease-free survival. The investigators concluded that "an immunotherapy approach integrated with chemoradiation is safe and effective for resected pancreas cancer."
The 60 patient Phase II study was conducted by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. The research was funded by the National Institutes of Health and other foundations. BioSante's Pancreas Cancer Vaccine is made from allogeneic pancreatic cancer cells genetically altered to produce an immune system stimulator called GM-CSF, and irradiated to prevent cell growth. BioSante already has received Orphan Drug designation from the U.S. Food & Drug Administration for the Pancreas Cancer Vaccine.”
Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03031.asp
More info: About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal : www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Contact BioSante Pharmaceuticals
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220; azachary@mckinneychicago.com
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com
Investorideas.com Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com. (one thousand per month)
Disclaimer: The following news is paid for by BPAX (one thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com to become a biotech showcase stock or research biotech stocks
800 665 0411 cvanzant@investorideas.com
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).
Subscribe to:
Posts (Atom)